Wczytywanie kursów wyceny...
Prognoza
| Kupuj |
1 |
| Trzymaj |
0 |
| Sprzedaj |
0 |
Wiadomości Przejdź do aktualności
The Cannabist Company sells Virginia business to Curaleaf for $110 million
The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Więcej na de.investing.com
Cannabist Company reports revenue decline and falling EBITDA in Q3 2025
Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Więcej na de.investing.com
Cannabist Company reports revenue decline and share price loss due to restructuring
Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Więcej na de.investing.com
Dane finansowe spółki
| (EUR) | wrzesień 2025 | YoY |
|---|---|---|
| Przychody | 68,1 mln | - |
| Zysk brutto | 19,52 mln | - |
| Zysk netto | -12,15 mln | - |
| EBITDA | 6,65 mln | - |
Dane fundamentalne
| Wskaźnik | Wartość |
|---|---|
Kapitalizacja rynkowa | 12,92 mln € |
Liczba akcji | 497,46 mln |
Maksimum/minimum z 52 tygodni | 0,14 € - 0,0178 € |
| Dywidendy | Nie |
Beta | 1,05 |
C/Z (PE Ratio) | -0,15 |
PEG (PEG Ratio) | 0,00 |
C/WK (PB Ratio) | -0,10 |
C/S (PS Ratio) | 0,09 |
Profil spółki
The Cannabist Company Holdings Inc. zajmuje się uprawą, produkcją i dostarczaniem produktów konopnych oraz powiązanych usług w Stanach Zjednoczonych i za granicą. Firma oferuje produkty obejmujące kwiaty, jadalne produkty, oleje i tabletki pod nazwami marek Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press i Amber. Posiada licencje w 17 jurysdykcjach w Stanach Zjednoczonych. Firma wcześniej funkcjonowała pod nazwą Columbia Care Inc. i zmieniła nazwę na The Cannabist Company Holdings Inc. we wrześniu 2023 roku. Firma została założona w 2012 roku i ma siedzibę główną w Nowym Jorku (New York, New York).
| Nazwa | Cannabist Co. Holdings Aktie |
| CEO | Christopher Marr |
| Siedziba | Malvern,
pa Stany Zjednoczone |
| Strona internetowa | |
| Debiut giełdowy | 29.04.2019 |
| Pracownicy | 2829 |
Symbole giełdowe
| Giełda | Symbol |
|---|---|
Neo | CBST.NE |
Pnk | CBSTF |
Frankfurt | VW5.F |
Düsseldorf | VW5.DU |
München | VW5.MU |